EP3636773
N-CADHERIN AND FGFR1 AND/OR FGFR4 FOR USE IN PREDICTING THE RESPONSE OF PATIENTS TO A LUNG CANCER TREATMENT AND METHOD AND KIT BASED ON SAID USE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
13.7.2018EP published:
23.8.2023EP application number:
18836033.3
EPO information:
European Patent Register
Max expiry date:
12.7.2038
Title in English:
N-CADHERIN AND FGFR1 AND/OR FGFR4 FOR USE IN PREDICTING THE RESPONSE OF PATIENTS TO A LUNG CANCER TREATMENT AND METHOD AND KIT BASED ON SAID USELanguage of the patent:
English
Timeline
Today
13.7.2018EP application
23.8.2023EP Publication
Owner
Name:
Fundación De Investigación Hospital 12 De OctubreAddress:
Avenida de Córdoba s/n Hospital Universitario 12 de Octubre Centro de Actividades Ambulatorias 6ª Planta Bloque D, 28041 Madrid, ES
Name:
Servicio Andaluz de SaludAddress:
Avda. de la Constitución 18, 41071 Sevilla, ES
Name:
Consejo Superior de Investigaciones Científicas (CSIC)Address:
Avda. María Luisa S/N Pabellón de Perú, 41013 Sevilla, ES
Inventor
Name:
PAZ-ARES RODRÍGUEZ, LuisAddress:
28010 Madrid, ES
Name:
QUINTANAL VILLALONGA, ÁlvaroAddress:
41018 Sevilla, ES
Name:
FERRER SÁNCHEZ, IreneAddress:
28007 Madrid, ES
Name:
MOLINA PINELO, SoniaAddress:
41013 Sevilla, ES
Name:
CARNERO MOYA, AmancioAddress:
41020 Sevilla, ES
Priority
Number:
201730929Date:
13.7.2017Country:
ES
Classification
Categories:
C12Q 1/6886, A61P 35/00